Virtu Financial LLC Palisade Bio, Inc. Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 07, 2022
BUY
$0.11 - $83.85 $12,025 - $9.17 Million
109,321 New
109,321 $11,000
Q4 2021

Feb 17, 2022
SELL
$1.3 - $2.96 $22,895 - $52,131
-17,612 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$2.35 - $3.93 $1,381 - $2,310
-588 Reduced 3.23%
17,612 $47,000
Q2 2021

Sep 17, 2021
BUY
$3.49 - $11.34 $63,518 - $206,388
18,200 New
18,200 $74,000

About PALISADE BIO, INC.

PALI Quotes by TradingView
  • Ticker PALI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,240,200
  • Market Cap $122M
  • Description
  • Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...
More about PALI
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email